Picture of Dermapharm Holding SE logo

DMP — Dermapharm Holding SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

German stocks - Factors to watch on April 13

BERLIN/FRANKFURT, April 13 (Reuters) - The following are
some of the factors that may move German stocks on Tuesday:
    
    CORONAVIRUS
    Germany reported 10,810 new infections and 294 more deaths.
    The country plans make to regular COVID-19 tests compulsory
for firms. An amendment to occupational health and safety
regulations will be submitted to the cabinet on Tuesday.
 urn:newsml:reuters.com:*:nL4N2M53XC
    
    VOLKSWAGEN  VOWG_p.DE 
    The carmaker and trade union IG Metall have agreed on a wage
package, Deutschlandfunk said citing company sources. Details
were to be presented at a news conference Tuesday morning,
according to the broadcaster.
    
    AIRBUS  AIR.PA   AIRG.DE   
    The planemaker on Monday announced the biggest shake-up in
its top ranks since Chief Executive Guillaume Faury took the
helm two years ago, sparked by the departure of two key
executives.  urn:newsml:reuters.com:*:nL1N2M51TE
    
    DERMAPHARM  DMPG.DE  
    Full-year results due.      
        
    AUTODOC   
    The company seeks up to $12 billion value in a Frankfurt
IPO, Bloomberg reported.  urn:newsml:reuters.com:*:nL4N2M53XC
      
    ANALYSTS' VIEWS 
    E.ON SE  EONGn.DE : CREDIT SUISSE RAISES TARGET PRICE TO EUR
11 FROM EUR 10.30
    MTU AERO ENGINES AG MTXGn.DE: JP MORGAN CUTS PRICE TARGET TO
EUR 191 FROM EUR 193
    
        
    OVERSEAS STOCK MARKETS  
    Dow Jones  .DJI  -0.2%, S&P 500 .SPX  unchanged, Nasdaq
 .IXIC  -0.4% at close.  .N 
    Nikkei  .N225  +1.0%, Shanghai stocks  .SSEC  unchanged.
 .T   .SS 
    Time: 4:42 GMT
    
    
    ECONOMY  
    German March wholesale price index due at 0600 GMT. 
    German April ZEW indicator due at 0900 GMT. Economic
sentiment seen at +79.5, current conditions at -52.0.
    
    DIARIES  DE/DIARY 
    REUTERS TOP NEWS  TOP/NEWS 

 (Reporting by Berlin, Frankfurt and Gdansk newsrooms)
 ((frankfurt.newsroom@thomsonreuters.com; +49 30 2888 5169))

Recent news on Dermapharm Holding SE

See all news